Sphingolipid Metabolism in Cancer Signalling and Therapy

Overview

Journal Nat Rev Cancer

Specialty Oncology

Date 2017 Nov 18

PMID 29147025

Citations 540

Authors

Besim Ogretmen

Affiliations

Soon will be listed here.

Abstract

Sphingolipids, including the two central bioactive lipids ceramide and sphingosine-1-phosphate (S1P), have opposing roles in regulating cancer cell death and survival, respectively, and there have been exciting developments in understanding how sphingolipid metabolism and signalling regulate these processes in response to anticancer therapy. Recent studies have provided mechanistic details of the roles of sphingolipids and their downstream targets in the regulation of tumour growth and response to chemotherapy, radiotherapy and/or immunotherapy using innovative molecular, genetic and pharmacological tools to target sphingolipid signalling nodes in cancer cells. For example, structure-function-based studies have provided innovative opportunities to develop mechanism-based anticancer therapeutic strategies to restore anti-proliferative ceramide signalling and/or inhibit pro-survival S1P-S1P receptor (S1PR) signalling. This Review summarizes how ceramide-induced cellular stress mediates cancer cell death through various mechanisms involving the induction of apoptosis, necroptosis and/or mitophagy. Moreover, the metabolism of ceramide for S1P biosynthesis, which is mediated by sphingosine kinase 1 and 2, and its role in influencing cancer cell growth, drug resistance and tumour metastasis through S1PR-dependent or receptor-independent signalling are highlighted. Finally, studies targeting enzymes involved in sphingolipid metabolism and/or signalling and their clinical implications for improving cancer therapeutics are also presented.

Citing Articles

Supplementation with Lentil () Hull Soluble Dietary Fiber Ameliorates Sodium Dextran Sulfate-Induced Colitis and Behavioral Deficits via the Gut-Brain Axis.

Chen D, Bi X, Feng Q, Sun Y Foods. 2025; 14(5).

PMID: 40077572 PMC: 11898428. DOI: 10.3390/foods14050870.

Integrating multi-omics data to reveal the host-microbiota interactome in inflammatory bowel disease.

Su F, Su M, Wei W, Wu J, Chen L, Sun X Gut Microbes. 2025; 17(1):2476570.

PMID: 40063366 PMC: 11901428. DOI: 10.1080/19490976.2025.2476570.

Comprehensive analysis of TMEM9 in human tumors.

Zhang X, Zhou L, Wei S, Zhang X Discov Oncol. 2025; 16(1):276.

PMID: 40053281 PMC: 11889325. DOI: 10.1007/s12672-025-02040-1.

Melanophilin inhibit the growth and lymph node metastasis of triple negative breast cancer via the NONO-SPHK1-S1P axis.

Yao X, Yuen T, Qingchuan C, Jianjun Z, Yefu L, Shulan S J Transl Med. 2025; 23(1):284.

PMID: 40050909 PMC: 11887221. DOI: 10.1186/s12967-025-06240-9.

Dynamic Lipidome Reorganization in Response to Heat Shock Stress.

Solano L, Keshet U, Reinschmidt A, Chavez Y, Hulsy W, Fiehn O bioRxiv. 2025; .

PMID: 40027697 PMC: 11870493. DOI: 10.1101/2025.02.18.638884.

References

Zhang Y, Wang Y, Wan Z, Liu S, Cao Y, Zeng Z . Sphingosine kinase 1 and cancer: a systematic review and meta-analysis. PLoS One. 2014; 9(2):e90362. PMC: 3937388. DOI: 10.1371/journal.pone.0090362. View

Lewis C, Voelkel-Johnson C, Smith C . Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640. Oncotarget. 2016; 7(37):60181-60192. PMC: 5312377. DOI: 10.18632/oncotarget.11112. View

Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R . Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell. 1995; 82(3):405-14. DOI: 10.1016/0092-8674(95)90429-8. View

Koybasi S, Senkal C, Sundararaj K, Spassieva S, Bielawski J, Osta W . Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J Biol Chem. 2004; 279(43):44311-9. DOI: 10.1074/jbc.M406920200. View

Dressler K, Mathias S, Kolesnick R . Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science. 1992; 255(5052):1715-8. DOI: 10.1126/science.1313189. View

Etemadi N, Chopin M, Anderton H, Tanzer M, Rickard J, Abeysekera W . TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1. Elife. 2015; 4. PMC: 4769158. DOI: 10.7554/eLife.10592. View

Takabe K, Kim R, Allegood J, Mitra P, Ramachandran S, Nagahashi M . Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem. 2010; 285(14):10477-86. PMC: 2856255. DOI: 10.1074/jbc.M109.064162. View

van der Weyden L, Arends M, Campbell A, Bald T, Wardle-Jones H, Griggs N . Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature. 2017; 541(7636):233-236. PMC: 5603286. DOI: 10.1038/nature20792. View

Jiang W, Ogretmen B . Autophagy paradox and ceramide. Biochim Biophys Acta. 2013; 1841(5):783-92. PMC: 3960371. DOI: 10.1016/j.bbalip.2013.09.005. View

10.

Gupta V, Bhinge K, Hosain S, Xiong K, Gu X, Shi R . Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells. J Biol Chem. 2012; 287(44):37195-205. PMC: 3481319. DOI: 10.1074/jbc.M112.396390. View

11.

Qin Z, Dai L, Trillo-Tinoco J, Senkal C, Wang W, Reske T . Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma. Mol Cancer Ther. 2013; 13(1):154-64. PMC: 3918494. DOI: 10.1158/1535-7163.MCT-13-0466. View

12.

Eliyahu E, Park J, Shtraizent N, He X, Schuchman E . Acid ceramidase is a novel factor required for early embryo survival. FASEB J. 2007; 21(7):1403-9. DOI: 10.1096/fj.06-7016com. View

13.

Siskind L, Feinstein L, Yu T, Davis J, Jones D, Choi J . Anti-apoptotic Bcl-2 Family Proteins Disassemble Ceramide Channels. J Biol Chem. 2008; 283(11):6622-30. PMC: 2713582. DOI: 10.1074/jbc.M706115200. View

14.

Kawamori T, Kaneshiro T, Okumura M, Maalouf S, Uflacker A, Bielawski J . Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 2008; 23(2):405-14. PMC: 2630788. DOI: 10.1096/fj.08-117572. View

15.

Rosenbloom B, Weinreb N, Zimran A, Kacena K, Charrow J, Ward E . Gaucher disease and cancer incidence: a study from the Gaucher Registry. Blood. 2005; 105(12):4569-72. DOI: 10.1182/blood-2004-12-4672. View

16.

Saddoughi S, Ogretmen B . Diverse functions of ceramide in cancer cell death and proliferation. Adv Cancer Res. 2013; 117:37-58. DOI: 10.1016/B978-0-12-394274-6.00002-9. View

17.

Blom T, Li S, Dichlberger A, Back N, Kim Y, Loizides-Mangold U . LAPTM4B facilitates late endosomal ceramide export to control cell death pathways. Nat Chem Biol. 2015; 11(10):799-806. DOI: 10.1038/nchembio.1889. View

18.

Kim J, Park Y, Roh J, Cho K, Choi S, Nam S . Prognostic value of glucosylceramide synthase and P-glycoprotein expression in oral cavity cancer. Int J Clin Oncol. 2016; 21(5):883-889. DOI: 10.1007/s10147-016-0973-1. View

19.

Huitema K, van den Dikkenberg J, Brouwers J, Holthuis J . Identification of a family of animal sphingomyelin synthases. EMBO J. 2003; 23(1):33-44. PMC: 1271672. DOI: 10.1038/sj.emboj.7600034. View

20.

Lee A, Roylance R, Sander J, Gorman P, Endesfelder D, Kschischo M . CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy induction. J Pathol. 2011; 226(3):482-94. DOI: 10.1002/path.2998. View